Ireland
--:--IST
Latest
Clinical Trials in Sweden / NCT05863598
Recruiting Not applicable

Prevention of Eating Disorders Through Optimization of Protective Factors

NCT05863598 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2023-05-15
Last updated
2025-03-06

Condition(s) studied

Body DissatisfactionEating Disorders

Investigational drug(s) / intervention(s)

Enhancing protective factorsExpressive writing

Enhancing protective factors: Participants will watch some short movies and infographics, and will be asked to argue for the importance of body image flexibility, body functionality appreciation, etc.

Expressive writing: Participants will reflect and write about any cognitions or emotions they can have in relation to their bodies.

Study summary

The goal of thin randomized controlled trial is to investigate the efficacy of a prevention program for reducing the incidence of eating disorders among youth (15-20). We target youth at these ages who experience a subjective sense of body dissatisfaction, and are thus at increased risk of developing an eating disorder.

The prevention program is based on improving protective factors such as body appreciation, body image flexibility, intuitive eating, and acceptance. It will be compared to a credible placebo (expressive writing).

Eligibility

Sex
ALL
Min age
15 Years
Max age
20 Years
Healthy volunteers
Accepted
Inclusion Criteria: Youth and young people (15-20 years) with a subjective experience of body dissatisfaction. Exclusion Criteria: Indications of depression, or suicidality, as well as presence of an eating disorder, or other conditions that may require medical attention, or conditions that makes it impossible to complete the intervention (e.g., not being able to read and write in Swedish).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Karolinska Institutet Solna Sweden Recruiting

More Karolinska Institutet trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05863598 on ClinicalTrials.gov ↗ ← All trials in Sweden